Wullschleger et al. demonstrated that cerebrospinal fluid (CSF) IL-6 levels exceeding 10 pg/mL could exclude MS with 96% sensitivity, potentially aiding in distinguishing MS from other differential diagnoses (28). The gene discussed is IL6; the disease is myeloid sarcoma.